{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:46:15Z","timestamp":1788486375541,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100015401","name":"Key Research and Development Projects of Shaanxi Province","doi-asserted-by":"publisher","award":["2024SF-ZDCYL-02-08"],"award-info":[{"award-number":["2024SF-ZDCYL-02-08"]}],"id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172798"],"award-info":[{"award-number":["82172798"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s10549-025-07763-x","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T14:38:14Z","timestamp":1751294294000},"page":"101-114","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The DCIS\u2013IBC guide board on predicting postoperative upgrading in breast ductal carcinoma in situ: clinical insights from a multicenter study"],"prefix":"10.1007","volume":"213","author":[{"given":"Chenglong","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsui","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhe","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"7763_CR1","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1001\/jamaoncol.2015.2607","volume":"1","author":"L Esserman","year":"2015","unstructured":"Esserman L, Yau C (2015) Rethinking the standard for ductal carcinoma in situ treatment. JAMA Oncol 1:881\u2013883. https:\/\/doi.org\/10.1001\/jamaoncol.2015.2607","journal-title":"JAMA Oncol"},{"key":"7763_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70:7\u201330. https:\/\/doi.org\/10.3322\/caac.21590","journal-title":"CA Cancer J Clin"},{"key":"7763_CR3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10549-005-9101-z","volume":"97","author":"B Erbas","year":"2006","unstructured":"Erbas B, Provenzano E, Armes J, Gertig D (2006) The natural history of ductal carcinoma in situ of the breast: a review. Breast Cancer Res Treat 97:135\u2013144. https:\/\/doi.org\/10.1007\/s10549-005-9101-z","journal-title":"Breast Cancer Res Treat"},{"key":"7763_CR4","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/jnci\/djy220","volume":"111","author":"MD Ryser","year":"2019","unstructured":"Ryser MD, Weaver DL, Zhao F, Worni M, Grimm LJ, Gulati R et al (2019) Cancer outcomes in DCIS patients without locoregional treatment. J Natl Cancer Inst 111:952\u2013960. https:\/\/doi.org\/10.1093\/jnci\/djy220","journal-title":"J Natl Cancer Inst"},{"key":"7763_CR5","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1002\/cncr.21069","volume":"103","author":"ME Sanders","year":"2005","unstructured":"Sanders ME, Schuyler PA, Dupont WD, Page DL (2005) The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer 103:2481\u20132484. https:\/\/doi.org\/10.1002\/cncr.21069","journal-title":"Cancer"},{"key":"7763_CR6","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.pathol.2019.07.005","volume":"51","author":"SS Badve","year":"2019","unstructured":"Badve SS, G\u00f6kmen-Polar Y (2019) Ductal carcinoma in situ of breast: update 2019. Pathology 51:563\u2013569. https:\/\/doi.org\/10.1016\/j.pathol.2019.07.005","journal-title":"Pathology"},{"key":"7763_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-026797","volume":"9","author":"ES Hwang","year":"2019","unstructured":"Hwang ES, Hyslop T, Lynch T, Frank E, Pinto D, Basila D et al (2019) The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS). BMJ Open 9:e026797. https:\/\/doi.org\/10.1136\/bmjopen-2018-026797","journal-title":"BMJ Open"},{"key":"7763_CR8","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1016\/j.ejca.2015.07.017","volume":"51","author":"A Francis","year":"2015","unstructured":"Francis A, Thomas J, Fallowfield L, Wallis M, Bartlett JM, Brookes C et al (2015) Addressing overtreatment of screen detected DCIS; the LORIS trial. Eur J Cancer 51:2296\u20132303. https:\/\/doi.org\/10.1016\/j.ejca.2015.07.017","journal-title":"Eur J Cancer"},{"key":"7763_CR9","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.ejca.2015.05.008","volume":"51","author":"LE Elshof","year":"2015","unstructured":"Elshof LE, Tryfonidis K, Slaets L, van Leeuwen-Stok AE, Skinner VP, Dif N et al (2015) Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study. Eur J Cancer 51:1497\u20131510. https:\/\/doi.org\/10.1016\/j.ejca.2015.05.008","journal-title":"Eur J Cancer"},{"key":"7763_CR10","doi-asserted-by":"publisher","unstructured":"Hwang, E. Shelley, Terry Hyslop, Thomas Lynch, Marc D. Ryser, Anna Weiss, Anna Wolf, et al. Active Monitoring With or Without Endocrine Therapy for Low-Risk Ducta l Carcinoma In Situ: The COMET Randomized Clinical Trial. JAMA:https:\/\/doi.org\/10.1001\/jama.2024.26698https:\/\/doi.org\/10.1001\/jama.2024.26698","DOI":"10.1001\/jama.2024.26698"},{"key":"7763_CR11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10549-020-06042-1","volume":"187","author":"D Byng","year":"2021","unstructured":"Byng D, Ret\u00e8l VP, Schaapveld M, Wesseling J, van Harten WH (2021) Treating (low-risk) DCIS patients: What can we learn from real-world cancer registry evidence? Breast Cancer Res Treat 187:187\u2013196. https:\/\/doi.org\/10.1007\/s10549-020-06042-1","journal-title":"Breast Cancer Res Treat"},{"key":"7763_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41416-019-0478-6","volume":"121","author":"M van Seijen","year":"2019","unstructured":"van Seijen M, Lips EH, Thompson AM, Nik-Zainal S, Futreal A, Hwang ES et al (2019) Ductal carcinoma in situ: to treat or not to treat, that is the question. Br J Cancer 121:285\u2013292. https:\/\/doi.org\/10.1038\/s41416-019-0478-6","journal-title":"Br J Cancer"},{"key":"7763_CR13","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.1245\/s10434-017-6018-9","volume":"24","author":"LJ Grimm","year":"2017","unstructured":"Grimm LJ, Ryser MD, Partridge AH, Thompson AM, Thomas JS, Wesseling J et al (2017) Surgical upstaging rates for vacuum assisted biopsy proven DCIS: implications for active surveillance trials. Ann Surg Oncol 24:3534\u20133540. https:\/\/doi.org\/10.1245\/s10434-017-6018-9","journal-title":"Ann Surg Oncol"},{"key":"7763_CR14","first-page":"1183","volume":"34","author":"JC Hogue","year":"2014","unstructured":"Hogue JC, Morais L, Provencher L, Desbiens C, Poirier B, Poirier \u00c9 et al (2014) Characteristics associated with upgrading to invasiveness after surgery of a DCIS diagnosed using percutaneous biopsy. Anticancer Res 34:1183\u20131191","journal-title":"Anticancer Res"},{"key":"7763_CR15","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.breast.2012.06.012","volume":"21","author":"J Kim","year":"2012","unstructured":"Kim J, Han W, Lee JW, You JM, Shin HC, Ahn SK et al (2012) Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision. Breast 21:641\u2013645. https:\/\/doi.org\/10.1016\/j.breast.2012.06.012","journal-title":"Breast"},{"key":"7763_CR16","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s12282-018-0871-7","volume":"25","author":"Y Watanabe","year":"2018","unstructured":"Watanabe Y, Anan K, Saimura M, Koga K, Fujino M, Mine M et al (2018) Upstaging to invasive ductal carcinoma after mastectomy for ductal carcinoma in situ: predictive factors and role of sentinel lymph node biopsy. Breast Cancer 25:663\u2013670. https:\/\/doi.org\/10.1007\/s12282-018-0871-7","journal-title":"Breast Cancer"},{"key":"7763_CR17","doi-asserted-by":"publisher","first-page":"312","DOI":"10.20892\/j.issn.2095-3941.2018.0159","volume":"16","author":"J Si","year":"2019","unstructured":"Si J, Yang B, Guo R, Huang N, Quan C, Ma L et al (2019) Factors associated with upstaging in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy. Cancer Biol Med 16:312\u2013318. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2018.0159","journal-title":"Cancer Biol Med"},{"key":"7763_CR18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1148\/radiol.11102368","volume":"260","author":"ME Brennan","year":"2011","unstructured":"Brennan ME, Turner RM, Ciatto S, Marinovich ML, French JR, Macaskill P et al (2011) Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer. Radiology 260:119\u2013128. https:\/\/doi.org\/10.1148\/radiol.11102368","journal-title":"Radiology"},{"key":"7763_CR19","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1245\/s10434-017-5927-y","volume":"24","author":"JW Jakub","year":"2017","unstructured":"Jakub JW, Murphy BL, Gonzalez AB, Conners AL, Henrichsen TL, S. th Maimone, et al (2017) A validated nomogram to predict upstaging of ductal carcinoma in situ to invasive disease. Ann Surg Oncol 24:2915\u20132924. https:\/\/doi.org\/10.1245\/s10434-017-5927-y","journal-title":"Ann Surg Oncol"},{"key":"7763_CR20","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.breast.2012.06.009","volume":"21","author":"C Trentin","year":"2012","unstructured":"Trentin C, Dominelli V, Maisonneuve P, Menna S, Bazolli B, Luini A et al (2012) Predictors of invasive breast cancer and lymph node involvement in ductal carcinoma in situ initially diagnosed by vacuum-assisted breast biopsy: experience of 733 cases. Breast 21:635\u2013640. https:\/\/doi.org\/10.1016\/j.breast.2012.06.009","journal-title":"Breast"},{"key":"7763_CR21","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/jso.24037","volume":"112","author":"T Kondo","year":"2015","unstructured":"Kondo T, Hayashi N, Ohde S, Suzuki K, Yoshida A, Yagata H et al (2015) A model to predict upstaging to invasive carcinoma in patients preoperatively diagnosed with ductal carcinoma in situ of the breast. J Surg Oncol 112:476\u2013480. https:\/\/doi.org\/10.1002\/jso.24037","journal-title":"J Surg Oncol"},{"key":"7763_CR22","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1002\/bjs.9337","volume":"100","author":"SK Lee","year":"2013","unstructured":"Lee SK, Yang JH, Woo SY, Lee JE, Nam SJ (2013) Nomogram for predicting invasion in patients with a preoperative diagnosis of ductal carcinoma in situ of the breast. Br J Surg 100:1756\u20131763. https:\/\/doi.org\/10.1002\/bjs.9337","journal-title":"Br J Surg"},{"key":"7763_CR23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.diii.2017.01.001","volume":"98","author":"DA Spak","year":"2017","unstructured":"Spak DA, Plaxco JS, Santiago L, Dryden MJ, Dogan BE (2017) BI-RADS(\u00ae) fifth edition: A summary of changes. Diagn Interv Imaging 98:179\u2013190. https:\/\/doi.org\/10.1016\/j.diii.2017.01.001","journal-title":"Diagn Interv Imaging"},{"key":"7763_CR24","doi-asserted-by":"publisher","unstructured":"Members of Breast Cancer Expert Panel on Consensus on Pathological Diagnosis of Ductal Carcinoma In Situ of Breast (2022) Consensus on pathological diagnosis of ductal carcinoma in situ of breast (2022 version). Chinese Journal of Pathology 51:812\u2013818. https:\/\/doi.org\/10.3760\/cma.j.cn112151-20220510-00389","DOI":"10.3760\/cma.j.cn112151-20220510-00389"},{"key":"7763_CR25","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/852748","volume":"2014","author":"N Iqbal","year":"2014","unstructured":"Iqbal N, Iqbal N (2014) Human epidermal growth factor receptor 2 (HER2) in cancers: overexpression and therapeutic implications. Mol Biol Int 2014:852748. https:\/\/doi.org\/10.1155\/2014\/852748","journal-title":"Mol Biol Int"},{"key":"7763_CR26","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s12282-015-0636-5","volume":"23","author":"Y Sato","year":"2016","unstructured":"Sato Y, Kinoshita T, Suzuki J, Jimbo K, Asaga S, Hojo T et al (2016) Preoperatively diagnosed ductal carcinoma in situ: risk prediction of invasion and effects on axillary management. Breast Cancer 23:761\u2013770. https:\/\/doi.org\/10.1007\/s12282-015-0636-5","journal-title":"Breast Cancer"},{"key":"7763_CR27","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.breast.2018.09.004","volume":"42","author":"EV Holm-Rasmussen","year":"2018","unstructured":"Holm-Rasmussen EV, Jensen MB, Balslev E, Kroman N, Tvedskov TF (2018) Risk factors of sentinel and non-sentinel lymph node metastases in patients with ductal carcinoma in situ of the breast: A nationwide study. Breast 42:128\u2013132. https:\/\/doi.org\/10.1016\/j.breast.2018.09.004","journal-title":"Breast"},{"key":"7763_CR28","doi-asserted-by":"publisher","unstructured":"Lee, Christoph I. and Joann G. Elmore. (2025) FDA breast density reporting requirements and evidence-based medical practice. JAMA:https:\/\/doi.org\/10.1001\/jama.2025.0001","DOI":"10.1001\/jama.2025.0001"},{"key":"7763_CR29","doi-asserted-by":"publisher","unstructured":"Kerlikowske, Karla, Michael C. S. Bissell, Brian L. Sprague, Jeffrey A. Tice, Katherine Y. Tossas, Erin J. A. Bowles, et al. Impact of BMI on Prevalence of Dense Breasts by Race and Ethnicity. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 32:1524\u20131530 https:\/\/doi.org\/10.1158\/1055-9965.EPI-23-0049","DOI":"10.1158\/1055-9965.EPI-23-0049"},{"key":"7763_CR30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.clinimag.2020.11.050","volume":"73","author":"SL Venkatesh","year":"2021","unstructured":"Venkatesh SL, Oseni TO, Bahl M (2021) Symptomatic ductal carcinoma in situ (DCIS): Upstaging risk and predictors. Clin Imaging 73:101\u2013107. https:\/\/doi.org\/10.1016\/j.clinimag.2020.11.050","journal-title":"Clin Imaging"},{"key":"7763_CR31","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1097\/js9.0000000000000257","volume":"109","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Li J, Mo M, Shen J, Ren H, Li S et al (2023) The comparison of efficacy and safety evaluation of vacuum-assisted Elite 10-G system and the traditional BARD 14-G core needle in breast diagnosis: an open-label, parallel, randomized controlled trial. Int J Surg 109:1180\u20131187. https:\/\/doi.org\/10.1097\/js9.0000000000000257","journal-title":"Int J Surg"},{"key":"7763_CR32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1477-7819-9-87","volume":"9","author":"SP Povoski","year":"2011","unstructured":"Povoski SP, Jimenez RE, Wang WP (2011) Ultrasound-guided diagnostic breast biopsy methodology: retrospective comparison of the 8-gauge vacuum-assisted biopsy approach versus the spring-loaded 14-gauge core biopsy approach. World J Surg Oncol 9:87. https:\/\/doi.org\/10.1186\/1477-7819-9-87","journal-title":"World J Surg Oncol"},{"key":"7763_CR33","doi-asserted-by":"publisher","unstructured":"Chinese Association of Breast Surgery (2019) Consensus statements and operation guidelines on breast lesions and lymph nodes biopsy guided by ultrasound. Zhonghua Wai Ke Za Zhi 57:404\u2013407. https:\/\/doi.org\/10.3760\/cma.j.issn.0529-5815.2019.06.002","DOI":"10.3760\/cma.j.issn.0529-5815.2019.06.002"},{"key":"7763_CR34","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s10549-006-9167-2","volume":"98","author":"A Goyal","year":"2006","unstructured":"Goyal A, Douglas-Jones A, Monypenny I, Sweetland H, Stevens G, Mansel RE (2006) Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases. Breast Cancer Res Treat 98:311\u2013314. https:\/\/doi.org\/10.1007\/s10549-006-9167-2","journal-title":"Breast Cancer Res Treat"},{"key":"7763_CR35","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/480840","volume":"2014","author":"O Coufal","year":"2014","unstructured":"Coufal O, Selingerov\u00e1 I, Vrt\u011blov\u00e1 P, Krsi\u010dka P, Gabrielov\u00e1 L, Fabian P et al (2014) A simple model to assess the probability of invasion in ductal carcinoma in situ of the breast diagnosed by needle biopsy. Biomed Res Int 2014:480840. https:\/\/doi.org\/10.1155\/2014\/480840","journal-title":"Biomed Res Int"},{"key":"7763_CR36","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/jso.23273","volume":"107","author":"HS Park","year":"2013","unstructured":"Park HS, Park S, Cho J, Park JM, Kim SI, Park BW (2013) Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy. J Surg Oncol 107:388\u2013392. https:\/\/doi.org\/10.1002\/jso.23273","journal-title":"J Surg Oncol"},{"key":"7763_CR37","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/cas.12381","volume":"105","author":"T Osako","year":"2014","unstructured":"Osako T, Iwase T, Ushijima M, Horii R, Fukami Y, Kimura K et al (2014) Incidence and prediction of invasive disease and nodal metastasis in preoperatively diagnosed ductal carcinoma in situ. Cancer Sci 105:576\u2013582. https:\/\/doi.org\/10.1111\/cas.12381","journal-title":"Cancer Sci"},{"key":"7763_CR38","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.semcancer.2020.04.002","volume":"72","author":"A Conti","year":"2021","unstructured":"Conti A, Duggento A, Indovina I, Guerrisi M, Toschi N (2021) Radiomics in breast cancer classification and prediction. Semin Cancer Biol 72:238\u2013250. https:\/\/doi.org\/10.1016\/j.semcancer.2020.04.002","journal-title":"Semin Cancer Biol"},{"key":"7763_CR39","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.3349\/ymj.2019.60.11.1028","volume":"60","author":"S Kim","year":"2019","unstructured":"Kim S, Kim J, Park HS, Kim HY, Lee K, Lee J et al (2019) An updated nomogram for predicting invasiveness in preoperative ductal carcinoma in situ of the breast. Yonsei Med J 60:1028\u20131035. https:\/\/doi.org\/10.3349\/ymj.2019.60.11.1028","journal-title":"Yonsei Med J"},{"key":"7763_CR40","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1007\/s00330-015-3807-z","volume":"25","author":"RM Mann","year":"2015","unstructured":"Mann RM, Balleyguier C, Baltzer PA, Bick U, Colin C, Cornford E et al (2015) Breast MRI: EUSOBI recommendations for women\u2019s information. Eur Radiol 25:3669\u20133678. https:\/\/doi.org\/10.1007\/s00330-015-3807-z","journal-title":"Eur Radiol"},{"key":"7763_CR41","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078276","volume":"386","author":"O Efthimiou","year":"2024","unstructured":"Efthimiou O, Seo M, Chalkou K, Debray T, Egger M, Salanti G (2024) Developing clinical prediction models: a step-by-step guide. BMJ 386:e078276. https:\/\/doi.org\/10.1136\/bmj-2023-078276","journal-title":"BMJ"},{"key":"7763_CR42","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.breast.2013.03.009","volume":"22","author":"HS Park","year":"2013","unstructured":"Park HS, Kim HY, Park S, Kim EK, Kim SI, Park BW (2013) A nomogram for predicting underestimation of invasiveness in ductal carcinoma in situ diagnosed by preoperative needle biopsy. Breast 22:869\u2013873. https:\/\/doi.org\/10.1016\/j.breast.2013.03.009","journal-title":"Breast"},{"key":"7763_CR43","doi-asserted-by":"publisher","first-page":"7069","DOI":"10.1245\/s10434-023-13929-y","volume":"30","author":"CJC Meurs","year":"2023","unstructured":"Meurs CJC, van Bekkum S, van Rosmalen J, Menke-Pluijmers MBE, Siesling S, Westenend PJ (2023) Validation and clinical utility of a prediction model for the risk of upstaging to invasive breast cancer after a biopsy diagnosis ductal carcinoma in situ. Ann Surg Oncol 30:7069\u20137080. https:\/\/doi.org\/10.1245\/s10434-023-13929-y","journal-title":"Ann Surg Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07763-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-025-07763-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07763-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T16:02:35Z","timestamp":1752508955000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-025-07763-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["7763"],"URL":"https:\/\/doi.org\/10.1007\/s10549-025-07763-x","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,30]]},"assertion":[{"value":"6 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki and approved by Ethics Committee of the First Affiliated Hospital of Xi\u2019an Jiaotong University. (Ethics No.KYLLSL-2024-728-02).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}